The multistep synthesis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one 15 has been carried out. The compound showed antiproliferative and apoptotic effects against K562, K562-R (imatinib mesilate resistant), HL60 and multidrug resistant (MDR) HL60 cell lines. Compound 15 showed a pro-apoptotic activity against HL60 and K562 resistant cell lines markedly higher than etoposide and busulfan, respectively. Flow cytometry studies carried out on K562 cells allowed to establish that 15 induces G0-G1 phase arrest followed by apoptosis.

MAGGIO, B., RAFFA, D., RAIMONDI, M.V., CASCIOFERRO, S., PLESCIA, F., TOLOMEO, ., et al. (2008). Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 43, 2386-2394 [10.1016/j.ejmech.2008.01.007].

Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one

MAGGIO, Benedetta;RAFFA, Demetrio;RAIMONDI, Maria Valeria;CASCIOFERRO, Stella Maria;PLESCIA, Fabiana;MANCUSO, Salvatrice;DAIDONE, Giuseppe
2008-01-01

Abstract

The multistep synthesis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one 15 has been carried out. The compound showed antiproliferative and apoptotic effects against K562, K562-R (imatinib mesilate resistant), HL60 and multidrug resistant (MDR) HL60 cell lines. Compound 15 showed a pro-apoptotic activity against HL60 and K562 resistant cell lines markedly higher than etoposide and busulfan, respectively. Flow cytometry studies carried out on K562 cells allowed to establish that 15 induces G0-G1 phase arrest followed by apoptosis.
2008
MAGGIO, B., RAFFA, D., RAIMONDI, M.V., CASCIOFERRO, S., PLESCIA, F., TOLOMEO, ., et al. (2008). Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 43, 2386-2394 [10.1016/j.ejmech.2008.01.007].
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0223523408000123-main.pdf

Solo gestori archvio

Descrizione: pdf
Dimensione 647.04 kB
Formato Adobe PDF
647.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/39024
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact